Skip to main content

Home/ Cancer/ Group items tagged mechanisms Coptidis_Rhizoma

Rss Feed Group items tagged

Matti Narkia

Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional ... - 0 views

    Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.
    Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y.
    J Ethnopharmacol. 2009 Oct 29;126(1):5-17. Epub 2009 Aug 15.
    PMID: 19686830

    The modern evidences of treating cancer with Huanglian and berberine have a strong linkage with traditional concept and rules of using Huanglian in CM practice. As anticancer candidates with low toxicity, berberine and its altered structure, as well as Huanglian and its formulae, will attract scientists to pursue the potential anticancer effects and the mechanisms by using technologies of genomics, proteomics and other advanced approaches. On the other hand, relatively few in vivo studies have been conducted on anticancer effects of Huanglian and berberine. The clinical application of berberine or Huanglian as novel cancer therapeutic agents requires in vivo validations and further investigations of their anticancer mechanisms.
1 - 1 of 1
Showing 20 items per page